Entrepruener Clinician in Biotech

I am a physician in life sciences industry currently involved in the clinical development of innovative therapies in Oncology. Being a clinician and strong passion for science has helped me to work amongst some of the best scientific minds in this industry. I am also proud to state that I was part of the development team involved in 3 successful NDA submissions including 2 blockbuster drugs in oncology.( one for solid tumors and the other for B Cell malignancy) My extensive tenure in the industry and working with major industry players have provided me with excellent team management skills and relationship building helping me to connect with corporates, academias research centres and organizations to identify clinical and strategic needs to implement a successful clinical development plan. A very skilled professional who can connect the various dots needed for a drug approval & development strategy needed for successful filings. Holds active memberships with ASCO, ASH, AACR, ESMO, EHA, DIA, SOCRA, EPPIC Global, Tie Siliconvalley and SIPA.I have served in various sub committees within DIA including Clinical trial design, Clinical study end points, Safety & pharmacovigilance, Protocol writing and Quality risk management. I am also very passionate about technology and science based innovation and development in the field of of health care,drug discovery, research and development Areas of therapeutic expertise include Oncology including hematological and solid tumors, immunology, respiratory and CNS. My global clientele includes life science companies including Biotech/Pharma focused on making innovative targeted therapeutics and biomarker diagnostics primarily in the therapeutic areas of Hematology/Oncology, and immunology Clienteles include primarily Biotech, Pharmaceuticals, CRO, academias and research institutions. Have developed well established relationship with scientists, researchers, clinicians and KOL’s primarily in the oncology space. The job responsibilities and capabilities include protocol writing, clinical study design, review of the safety and efficacy data, monitor safety signals, act as clinical leads for various molecules in development and serve as the conduit between the KOL’s and the sponsor in the clinical setting and other aspects of writing including CSR’s and safety narratives.

Currently in the process of building an enterprise that transcends geographies and develop into one of the finest institutions in Oncological sciences from drug discovery and development to health care delivery by partnering with leading research and academic groups in India.

On my spare time i  actively participate and volunteer mentoring opportunties for alumni's from various schools including NYU stern, Upenn, UC Davis, Ross school of management, Rice University,Duke and Stanford.